InvestorsHub Logo
Followers 31
Posts 901
Boards Moderated 0
Alias Born 12/23/2009

Re: $5.95akadawson-m post# 131957

Tuesday, 12/08/2020 6:43:22 AM

Tuesday, December 08, 2020 6:43:22 AM

Post# of 232949
"The third expected EUA is from CytoDyn Inc. (OTCMKTS: CYDY). This is a repurposed monoclonal antibody that is the only remaining phase 3 drug candidate with a mortality benefit that has not had to resize its study after meeting an interim checkpoint. This drug has a stellar safety profile with over a thousand patients and no SAE’s related to the drug. It is an anomaly because leronlimab showed it actually reduced the side effects over placebo by as much as 60% in a phase 2 mild to moderate study. Now that’s a safe drug! The company is hosting an investor update on Thursday December 10, 2020 and may be close to finishing its trial. "

Woww! Very nice info. Thank you!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News